SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015237
Filing Date
2023-08-24
Accepted
2023-08-24 08:00:28
Documents
13
Period of Report
2023-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K apre-20230823x8k.htm   iXBRL 8-K 65204
  Complete submission text file 0001558370-23-015237.txt   196985

Data Files

Seq Description Document Type Size
2 EX-101.SCH apre-20230823.xsd EX-101.SCH 3904
3 EX-101.DEF apre-20230823_def.xml EX-101.DEF 2849
4 EX-101.LAB apre-20230823_lab.xml EX-101.LAB 17250
5 EX-101.PRE apre-20230823_pre.xml EX-101.PRE 11360
7 EXTRACTED XBRL INSTANCE DOCUMENT apre-20230823x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 231198930
SIC: 2834 Pharmaceutical Preparations